Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $105 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact [email protected].

Amir Zamani, MD

Amir Zamani, MD

Principal
Life Sciences
Boston

Experience

Dr. Zamani joined Bain Capital Life Sciences in 2018. He is a Principal.

Prior to joining Bain Capital, Dr. Zamani was a Partner at McKinsey & Company, where he was a leader in the Biopharmaceutical and Medical Products Practice. Before McKinsey, he was a resident in Plastic Surgery at the University of Pennsylvania.


Education

Dr. Zamani received his MD from The Johns Hopkins University School of Medicine, where he graduated Alpha Omega Alpha. He graduated Phi Beta Kappa from Stanford University with distinction in both Biological Sciences (BS) and Economics (BA).